Nab-Paclitaxel as new Therapeutic Option for Pancreatic Cancer

被引：0
|
作者：
Michl, P. [1 ]
机构：
[1] Univ Marburg, Klin Gastroenterol Endokrinol & Stoffwechsel, D-35043 Marburg, Germany
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2013年 / 51卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1329 / 1330
页数：2
相关论文
共 50 条
  • [31] Evaluation of Combination Treatment Benefits of nab-Paclitaxel in Experimental Pancreatic Cancer
    Awasthi, N.
    Ostapoff, K. T.
    Zhang, C.
    Schwarz, M. A.
    Schwarz, R. E.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S153 - S153
  • [32] FOLFOX and nab-paclitaxel (nab-P) for advanced pancreatic cancer: A phase I study
    Safran, Howard
    Charpentier, Kevin
    Perez, Kimberly
    Mantripragada, Kalyan
    Austin, Trevor Clark
    Nadeem, Omar
    Lombardo, Alise
    Houlihan, Lindsay
    Fontes-Borts, Lucia
    Kolberg, Irene
    Mitchell, Kristen
    Rosati, Kayla
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [33] Nab-Paclitaxel: a bright new SPARC in taxane therapy of cancer
    Ackland, Stephen P.
    Bull, James M.
    Boyle, Frances M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2009, 5 (03) : 147 - 150
  • [34] Predictors of vulnerability to nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
    Iede, Kiyotsugu
    Yamada, Terumasa
    Tominaga, Shusei
    ANNALS OF ONCOLOGY, 2023, 34 : S1453 - S1453
  • [35] Gemcitabine plus Nab-Paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC)
    Olowokure, Olugbenga
    Torregroza-Sanchez, Maria Patricia
    Bedoya-Apraez, Ivan Dario
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (02) : E16 - E18
  • [36] Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer
    Tsujimoto, Akiko
    Sudo, Kentaro
    Nakamura, Kazuyoshi
    Kita, Emiri
    Hara, Ryusuke
    Takayama, Wataru
    Ishii, Hiroshi
    Yamaguchi, Taketo
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [37] Evaluation of combination treatment benefits of nab-paclitaxel in experimental pancreatic cancer.
    Awasthi, Niranjan
    Ostapoff, Katherine
    Zhang, Changhua
    Schwarz, Margaret A.
    Schwarz, Roderich
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [38] Pomalidomide Enhanced Antitumor Effect of Gemcitabine and Nab-Paclitaxel for Pancreatic Cancer Cells
    Saito, Nobuhiro
    Shirai, Yoshihiro
    Sugano, Hiroshi
    Horiuchi, Takashi
    Iwase, Ryota
    Haruki, Koichiro
    Shiba, Hiroaki
    Uwagawa, Tadashi
    Ohashi, Toya
    Yanaga, Katsuhiko
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 223 (04) : E142 - E142
  • [39] Dosing Schedules of Gemcitabine and nab-Paclitaxel for Older Adults With Metastatic Pancreatic Cancer
    Winer, Arthur
    Handorf, Elizabeth
    Dotan, Efrat
    JNCI CANCER SPECTRUM, 2021, 5 (05)
  • [40] Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines
    Braun, Lukas M.
    Lagies, Simon
    Guenzle, Jessica
    Fichtner-Feigl, Stefan
    Wittel, Uwe A.
    Kammerer, Bernd
    CELLS, 2020, 9 (05)
12345